CRISM Therapeutics Corporation (AIM:CRTX)
London
· Delayed Price · Currency is GBP · Price in GBX 12.13
-0.88 (-6.73%)
Apr 29, 2026, 8:13 AM GMT
CRISM Therapeutics Market Cap
CRISM Therapeutics has a market cap or net worth of 6.73 million as of April 28, 2026. Its market cap has increased by 116.65% in one year.
Market Cap
6.73M
Enterprise Value
6.38M
Revenue
25.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
12.13
Market Cap Chart
Since March 15, 2006, CRISM Therapeutics's market cap has decreased from 28.23M to 6.73M, a decrease of -76.18%. That is a compound annual growth rate of -6.88%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| OptiBiotix Health | 5.53M |
| Cizzle Biotechnology Holdings | 8.32M |
| Futura Medical | 8.43M |
| Theracryf | 5.16M |
| Thalia Therapeutics | 4.79M |
| Nuformix | 4.70M |
| Oxford BioDynamics | 9.87M |
| Genflow Biosciences | 14.19M |